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The ability of unencapsulated (nontypeable) Haemophilus influenzae (NTHi) to cause systemic disease in
healthy children has been recognized only in the past decade. To determine the extent of similarity among
invasive nontypeable isolates, we compared strain R2866 with 16 additional NTHi isolates from blood and
spinal fluid, 17 nasopharyngeal or throat isolates from healthy children, and 19 isolates from middle ear
aspirates. The strains were evaluated for the presence of several genetic loci that affect bacterial surface
structures and for biochemical reactions that are known to differ among H. influenzae strains. Eight strains,
including four blood isolates, shared several properties with R2866: they were biotype V (indole and ornithine
decarboxylase positive, urease negative), contained sequence from the adhesin gene hia, and lacked a genetic
island flanked by the infA and ksgA genes. Multilocus sequence typing showed that most biotype V isolates
belonged to the same phylogenetic cluster as strain R2866. When present, the infA-ksgA island contains
lipopolysaccharide biosynthetic genes, either lic2B and lic2C or homologs of the losA and losB genes described
for Haemophilus ducreyi. The island was found in most nasopharyngeal and otitis isolates but was absent from
40% of invasive isolates. Overall, the 33 hmw-negative isolates were much more likely than hmw-containing
isolates to have tryptophanase, ornithine decarboxylase, or lysine decarboxylase activity or to contain the hif
genes. We conclude (i) that invasive isolates are genetically and phenotypically diverse and (ii) that certain
genetic loci of NTHi are frequently found in association among NTHi strains.
Haemophilus influenzae is a small, fastidious gram-negative
coccobacillus that colonizes the human nasopharynx, usually
without causing symptoms. When disease occurs, it is usually
limited to local infections of the respiratory tract such as otitis
media in young children, bronchitis or sinusitis in adults, or
pneumonia secondary to chronic pulmonary disease. Invasive
disease such as bacteremia or meningitis is currently uncom-
mon in the developed world and is nearly always associated
with strains possessing polysaccharide capsules. The six sero-
types of H. influenzae have capsules with different carbohy-
drate structures, with serotype b being the most common.
Since the introduction of conjugate vaccines against the type b
capsular polysaccharide, the incidence of life-threatening H.
influenzae infection has decreased substantially. As expected,
the vaccine has not affected the incidence of infections due to
unencapsulated (nontypeable) H. influenzae (NTHi). It was
once thought that invasive NTHi disease occurred only in
children with immunologic or anatomical defects that predis-
pose them to bacterial infections. More recently it has become
apparent that NTHi can cause bacteremia and meningitis in
otherwise healthy children. One of the first well-documented
cases of invasive NTHi was reported in 1996 (33), and since
then there have been several publications describing additional
cases (5, 6, 8, 34). It is not known whether NTHi isolates from
invasive infections possess virulence determinants not shared
with isolates associated with otitis media or isolates asymptom-
atically colonizing the nasopharynx. It is important to deter-
mine whether NTHi strains isolated from invasive infections
represent distinct lineages or have novel virulence genes not
shared with commensals or isolates from localized infections.
The genetic diversity of encapsulated H. influenzae and
NTHi has been studied using ribotyping, restriction fragment
length polymorphism (RFLP), multilocus enzyme electro-
phoresis, and multilocus sequence typing (MLST) (4, 26, 32,
43). Phylogenetic trees generated using these methods have
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shown that whereas encapsulated isolates cluster by serotype,
NTHi isolates are much more diverse, with less evidence of
clonality (26, 32). The extent to which disease isolates of NTHi
are phylogenetically similar has not been studied extensively.
van Alphen et al. reported that isolates from acute disease
(otitis media or meningitis) are less phylogenetically diverse
than isolates from chronic infection (cystic fibrosis or chronic
bronchitis) (43). Classically, H. influenzae strains were grouped
into “biotypes” by biochemical assays. Kilian (23) described a
system for biotyping H. influenzae based on the presence or
absence of three enzymatic activities: urease, ornithine decar-
boxylase, and the production of indole from tryptophan. Bio-
typing was useful because of weak correlations with pathoge-
nicity. Serotype b strains, particularly those isolated from
systemic disease, usually possess all three activities, making
them biotype I; conjunctival isolates are usually biotype III and
urogenital isolates type IV. Mucosal isolates, whether from
healthy children or associated with disease, are more diverse in
biotype (23). Indole production, associated with a tryptopha-
nase (tna) gene cluster and with several biotypes, is more
frequent in isolates from mucosal and invasive disease than in
commensals or in conjunctivitis (25).
Respiratory tract isolates differ in the fermentation of fruc-
tose, maltose, and xylose (22, 41). The API 20E system, devel-
oped for testing multiple biochemical reactions in clinical iso-
lates of Enterobacteriaceae, has shown several additional
activities to be present in some H. influenzae strains but not in
others, including arginine dihydrolase and lysine decarboxylase
activities and arabinose fermentation (18). For NTHi, none of
these biochemical activities has been shown to be strongly
associated with a specific disease or with asymptomatic car-
riage, though it has been noted that lower respiratory tract
isolates from patients with cystic fibrosis are more likely to
decarboxylate lysine than are other isolates (17).
Surface molecules of both NTHi strains and encapsulated H.
influenzae strains have been shown to be heterogeneous in a
variety of ways that may affect pathogenesis. The major outer
membrane proteins known as P1, P2, and P5 are particularly
diverse in sequence (2). Several genes involved in lipopolysac-
charide biosynthesis are variably present in H. influenzae
strains, and some of these are phase variable. The resulting
heterogeneity of lipopolysaccharide structure affects suscepti-
bility to complement-mediated serum killing and the interac-
tion of bacteria with host cells (40). H. influenzae isolates also
differ in protein adhesins: most contain genes for one of the
adhesins known as Hia and HMW, but not both, and some
strains are also able to synthesize fimbriae (38). A recent study
reported that otitis isolates are more likely than throat isolates
to contain hmw genes, while throat isolates were more likely
than isolates from blood or the middle ear to hybridize with a
probe for the hifBC genes (required for synthesis of fimbriae)
(10).
We undertook these studies to determine whether isolates of
NTHi associated with invasive disease differ phenotypically or
genetically from isolates cultured from healthy children or
associated with acute otitis media. We previously reported that
the invasive NTHi strain Int1 (later R2866) differs from most
NTHi strains in being unusually resistant to the bactericidal
activity of normal adult human serum (49). We have also found
that strain R2866 contains several genetic loci that are absent
from the sequenced strain Rd KW20 and from several non-
typeable strains. These include the gene for an autotrans-
porter, lav, located between holB and tmk (9), the lysogenic
bacteriophage HP2 (48), the tna cluster (25), and a 53-kb
plasmid similar to other large integrative plasmids of Hae-
mophilus spp. (28). In the present work a collection of 17 NTHi
isolates associated with invasive disease were compared with
isolates from healthy children or associated with acute otitis
media in order to determine whether invasive isolates are
genetically or phylogenetically distinct. We assayed the suscep-
tibility of each strain to complement-mediated killing by
pooled normal human serum and tested each in a panel of
biochemical assays. In addition, we used PCR to screen for the
presence of genes for HP2, Lav, fimbriae, and the adhesins Hia
and HMW, the 53-kb plasmid, and the lipopolysaccharide bio-
synthetic locus flanked by infA and ksgA. Invasive strains were
genetically heterogeneous and did not differ significantly in the
range of serum sensitivity from nasopharyngeal commensals or
otitis media isolates. However, several genetic characteristics
are not assorted randomly but are strongly associated with one
another. In particular, several biochemical and genetic traits
were found primarily in strains lacking genes for the hmw
adhesin. Within the hmw-negative group we identified a cluster
of eight isolates that resembled R2866 in being biotype V and
hia positive, lacking an infA-ksgA island, and having the urease
locus replaced by a homolog of the gonococcal membrane
protein mtrF. These strains were shown by MLST to be mem-
bers of a phylogenetic cluster.
MATERIALS AND METHODS
Bacterial strains and growth. H. influenzae strains are listed in Table 1. We
studied three types of isolates: nasopharyngeal or throat isolates from healthy
children, strains cultured from middle ear aspirates from children with otitis
media, and blood or cerebrospinal fluid isolates obtained from children with
invasive disease. For simplicity, isolates are referred to below as “throat,” “oti-
tis,” or “invasive.” Strains were isolated between 1995 and 2004, at different
locations within the United States, Canada, and Europe. For invasive isolates, we
limited the study to isolates from children who were considered by the treating
physician to have normal anatomy and immune function. Neonates were ex-
cluded. Otitis isolates included the recently sequenced strains 86-028NP (31) and
R2846 (strain 12). Invasive isolates included R2866 (Int1), which has also been
sequenced recently. Bacteria were cultivated at 37°C on chocolate agar supple-
mented with 1% IsovitaleX (Becton Dickinson and Co., Sparks, MD) or in Difco
brain heart infusion broth (Becton Dickinson and Co.) supplemented (sBHI)
with hemin (10 g/ml) and -NAD (10 g/ml) and with agar for solid sBHI
plates. The requirement of all strains for X and V factors was confirmed by disk
diffusion. All strains were negative for bexA by PCR, indicating the inability to
express capsular polysaccharide. The serotype b strain Eagan was used as a
positive control for bexA PCR.
Biochemical assays. Bacteria were suspended at 108 CFU/ml in 0.9% NaCl
containing hemin (10 g/ml) and -NAD (10 g/ml) and were used to inoculate
API 20E biochemical test strips purchased from bioMerieux (St. Louis, MO)
(19). Enzyme activities and fermentation reactions were recorded after 24 h of
incubation at 37°C in air. Indole, ornithine decarboxylase, and urease activities
were used for biotyping (23).
Screen for genetic markers by PCR. Genomic DNA was prepared using the
DNeasy tissue kit (QIAGEN, Inc., Valencia, CA). Primers (Table 2) were syn-
thesized by Integrated DNA Technologies, Coralville, IA. For lav, we amplified
across the holB-tmk junction (HI0455 to HI0456 in Rd KW20). Positive strains
yielded a product of 2 to 2.2 kb. Partial sequencing confirmed that all were
related to the published sequence of lav. The remaining isolates did not yield an
amplicon or else produced a 150-bp product consistent with no inserted gene.
For detection of bacteriophage HP2, we used PCR to amplify regions of rep
(common to both phage HP1 and HP2) and orf10 (specific for HP2). For the
plasmid, PCR with the primers listed as topoF and topoR gave a product of
about 450 bp, and primers AF and AR gave a product of about 500 bp. We used
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primers designed to amplify conserved regions of the adhesin genes hmwA and
hia (36, 44). PCR with the hmw primers gave a product of approximately 1.2 kb.
Occasional faint products were sequenced and were scored negative if the se-
quences were not related to hmwA. hia products were usually 3 to 4 kb but
ranged from approximately 0.75 kb to 10 kb. The basis of this size difference was
not evaluated. Ten of the hia amplicons were sequenced and found to be similar
to the published hia sequence. Of four strains yielding hia products of only 0.75
kb, two were sequenced and found to be homologous to the 3 end of the hia
gene. All of these hia-related sequences were scored as positive for hia. The
presence and size of the hif locus, required for synthesis of fimbriae, was eval-
uated by amplification across the purE-pepN junction. Isolates with a complete
hif locus produced a product of approximately 7 kb. These PCR fragments were
sequenced using the purE primer to detect the presence of hicA and hicB in
addition to the hif genes. As seen previously (27), the remaining isolates con-
tained either a shorter purE-pepN insert, reflected by a product of approximately
0.5 to 1 kb (presumed to include hicAB), or no insert, reflected by a PCR product
of approximately 250 bp. The genetic island flanked by infA and ksgA was
detected by PCR across the infA-ksgA junction. The contents of the 2.2-kb island
were determined either by sequencing or by PCR using primers infA and losB-R
to detect losAB and primers lic2B-F and lic2BA to detect lic2BC. Routine PCR
was carried out using the Biolase DNA polymerase (Bioline USA, Randolph,
MA), with the following amplification protocol: reaction tubes were incubated at
94°C for 2 min, then for 36 cycles of 94°C for 30 s, 55°C for 30 s, and 72°C for 1
min per kb of predicted product. The Expand Long Template PCR system
(Roche Diagnostics Company, Indianapolis, IN) was used as directed for ampli-
fication of the hif and hia loci. Following electrophoresis, ethidium bromide-
stained agarose gels were visualized and photographed using the Fluorochem
8900 digital imaging system (Alpha Innotech Corporation, San Leandro, CA).
PCR products to be sequenced were processed using the Qiaquick PCR purifi-
cation kit (QIAGEN, Inc.) and submitted to the core sequencing facility at
Seattle Biomedical Research Institute. Sequences were aligned using the BioEdit
Sequence Alignment Editor (Isis Pharmaceuticals, Inc., Carlsbad, CA).
MLST. PCR for the housekeeping genes adk, atpG, adk, atpG, frdB, fucK,
mdh, pgi, and recA was carried out using the primers and methods described in
reference 26. Sequences were submitted to the MLST website (www.mlst.net) for
allele and sequence type (ST) assignment.
Serum bactericidal activity. Log-phase bacteria (2,000 CFU/ml) were incu-
bated for 30 min at 37°C with pooled normal human serum diluted in 10 mM
phosphate-buffered saline containing 4 mM KCl and 0.1% gelatin and were then
plated to determine bacterial survival. The concentration of serum that killed
50% of bacteria was calculated using XLfit 4.1 (ID Business Solutions, Guild-
ford, United Kingdom) and is referred to as the IC50 of the serum for that strain.
Statistics. Groups were compared using the Fisher exact probability test.
Calculations were performed online using VassarStats: Web Site for Statistical
Computation (http://faculty.vassar.edu/lowry/VassarStats.html).
Sequence data. Sequences for the genomes of H. influenzae strains Rd KW20,
R2846, R2866, and 86-028NP and of Neisseria gonorrhoeae FA1090 and Neisseria
meningitidis strains MC58 and Z2491 were accessed through the Microbial Ge-
nomes pages at the website of the National Center for Biotechnology Informa-
tion (NCBI) (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi). The sequences
TABLE 1. Bacterial strains
Clinical source and strain no. (previous strain designation) Yr isolated; sourcea (reference)
Nasopharyngeal
C500 .................................................................................................................................1978; CHMC, Boston, MA
R3019 (A840162), R3020 (A930066), R3021 (A950077), R3022 (A950078),
R3023 (A950084), R3024 (A950085).......................................................................1984–1995; L. van Alphen, Amsterdam, The Netherlands
R3261 (32), R3262 (11), R3263 (18), R3264 (153), R3265 (510) ...........................1996–1997; J. Campos, Madrid, Spain
R3266 (K42-44), R3367 (K35-48), R3368 (K29-43), R3369 (K56-132),
R3370 (K157-51) ........................................................................................................1972–1982; F. Henderson, University of North Carolina
Middle ear
C68, C69, C447, C464, C470, C476, C486, C505, C507, C544, C1049,
C1344, C1626..............................................................................................................1977–1984; CHMC, Boston, MA, and CHRMC, Seattle, WA
R2846 (strain 12)............................................................................................................S. J. Barenkamp, St. Louis, MO (3)
R3140 (LKP1 P860295), R3141 (LKP4 P861249), R3142 (LKP5 P861384)..........B. A. Green, Wyeth Vaccines
R3157 (1128) ..................................................................................................................L. O. Bakaletz, Columbus, OH (37)
R3642 (86-028NP)..........................................................................................................R. S. Munson, Columbus, OH (1, 31)
Invasive—set 1b
C2965 (2).........................................................................................................................1995; K. Muhlemann (29)
R2866 (Int1) ...................................................................................................................1996; CHMC, Seattle, WA (33)
R3565...............................................................................................................................1999; M. M. Farley, Atlanta, GA (8)
R3566 (GA14939), R3567 (GA16143), R3568 (GA16385), R3569
(GA18074), R3570 (GA18390), R3571 (GA18503) ..............................................2000–2001; M. M. Farley, Atlanta, GAc
R3572 (765), R3577 (774), R3579 (776), R3583 (784), R3588 (789),
R3590 (794), R3601 (772).........................................................................................1993–2000; R. F. Jacobs, Little Rock, AR (34)
R3631...............................................................................................................................2004; R. F. Jacobs, Little Rock, AR
Invasive—set 2
R3595 (799), R3596 (800).............................................................................................1993–2000; R. F. Jacobs, Little Rock, AR (34)
R3169 (15), R3170 (52), R3171 (129), R3172 (134), R3173 (253),
R3174 (330), R3175 (378), R3176 (447), R3177 (455) .........................................1995; K. Muhlemann (29)
R3042 (Z1082), R3046 (Z1030), R3049 (Z202), R3050 (Z343), R3052
(Z1210), R3055 (Z378), R3060 (Z241), R3064 (Z960) ........................................1995–1996; C. Shaw, Vancouver, BC, Canada
Bronchitisd
R3101 (6173) ..................................................................................................................L. van Alphen, Amsterdam, The Netherlands (12)
a CHMC, Children’s Hospital and Medical Center; CHRMC, Children’s Hospital and Regional Medical Center; BC, British Columbia.
b The 17 isolates listed as “Invasive—set 1” were used for the data presented in Fig. 1 and in Tables 3, 4, and 5. The 19 isolates listed as “Invasive—set 2” were used
only for the data reported in the section of Results describing the infA-ksgA island.
c Isolates R3566 to R3571 were collected as part of the Active Bacterial Core Surveillance of the Georgia Emerging Infections Program, funded by the Centers for
Disease Control and Prevention.
d R3101 was isolated from a patient with chronic bronchitis. Data on this isolate are included in Table 3 and in the section of Results describing PstI restriction
patterns of the hif locus.
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of the mtrF (strain R2866) and losAB (strain R2846) loci were submitted to
NCBI and were assigned accession numbers DQ007025 and DQ007026, respec-
tively.
RESULTS
Biotyping and other biochemical characterization. For H.
influenzae type b, invasive isolates nearly always belong to
biotype I (positive for all three of the biotyping reactions), with
biotype II (negative for ornithine decarboxylase only) seen
occasionally (14). In contrast, of the invasive NTHi isolates
studied here, only one-third belonged to biotype I and about
one-fourth belonged to biotype V (negative for urease only)
(Table 3). We noted heterogeneity among strains in several
other biochemical reactions. Arginine dihydrolase and arabi-
nose fermentation were seen predominantly for throat isolates,
while lysine decarboxylase and growth on citrate were seen less
often for middle ear isolates than for the other two groups
(Table 3). In most cases these correlations were not statistically
significant.
Correlation of the hmwA gene with biochemical reactions
and genes for other surface molecules. We evaluated strains
for the presence of genes encoding the HMW adhesins by PCR
amplification of a conserved region of hmw1A and hmw2A.
The results correlated strongly with the biochemical reactions
discussed above and with the presence of genes encoding other
surface molecules (Table 3). hmw-negative isolates were much
more likely than hmw-positive isolates to be positive for indole,
ornithine decarboxylase, lysine decarboxylase, and arginine di-
hydrolase activities, to be negative for urease activity, and to
ferment arabinose and grow on citrate. hmw-negative isolates
were nearly always positive for hia-related sequences, as re-
ported previously (39). One isolate, R3579, contained se-
quences for both hmw and hia. This result was confirmed by
sequencing the products and by carrying out PCR on five
separate colonies. Each of the five colonies yielded both a hia
product (approximately 3 kb) and a hmw product, indicating
that the culture was not a mixture of a hia-positive and a
hmw-positive strain. We used PCR to determine the presence
and size of the fimbrial gene cluster flanked by purE and pepN.
We found that 11 isolates contained a 7-kb purE-pepN insert
consistent with a complete fimbrial biosynthetic locus; 10 of
these isolates were hmw negative. Of 15 isolates lacking a
purE-pepN insert, 14 were also hmw negative. Of the 20 hmw-
positive isolates, 18 had a purE-pepN insert of 0.8 to 1 kb. Such
inserts have been reported to contain two genes of unknown
function, hicA and hicB. This correlation between hmw and the
fimbrial gene cluster has not been reported previously.
Lipopolysaccharide biosynthetic island flanked by infA and
ksgA. The lipopolysaccharide biosynthetic genes now known as
lic2B and lic2C were initially described for a type b strain,
RM7004 (originally strain 760705 from the van Alphen labo-
ratory, isolated from cerebrospinal fluid). In this strain they are
flanked by infA and ksgA (homologs of HI0548 and HI0549 in
Rd KW20) (16, 20). Comparison of the infA-ksgA region in the
available H. influenzae genome sequences showed that in
strains Rd KW20 and R2866, the infA and ksgA genes are
adjacent. Strain 86-028NP contains a single gene, lic2C, sepa-
rating infA and ksgA. In strain R2846, infA and ksgA are sep-
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These genes are strongly homologous to losA and losB (also
known as lbgB and lbgA), characterized in Haemophilus ducreyi
as encoding -1,4-galactosyltransferase and D-glycero-D-
manno-heptosyltransferase, respectively (13, 42). The infA-
ksgA junction thus appears to be a site of substantial genetic
heterogeneity, with at least four complements of genes seen in
different isolates (Fig. 1).
We used PCR across the infA-ksgA junction to evaluate the
diversity of this region in the same 53 isolates that were used
for the biochemical studies described above. Most of the throat
and mucosal-disease isolates in our study contained a genetic
island of 2.2 kb. Of 12 isolates lacking the island, 6 were
invasive, 4 were otitis isolates, and only 2 were throat isolates.
Partial sequencing of the amplified ksg-infA regions showed
that the distribution of losAB and lic2BC-related sequences
differed among the three groups: only one invasive isolate, but
about one-quarter of throat and otitis isolates, contained
losAB-related sequences. Most of the remaining strains con-
tained lic2B and lic2C, but four contained only lic2C (Table 4).
These data suggest that invasive isolates of NTHi may be
less likely than other NTHi isolates to contain an island flanked
by infA and ksgA, and also less likely to contain an island
consisting of losAB. However, this is based on a fairly small
number of isolates. We used PCR to investigate the infA-ksgA
regions of 19 additional invasive isolates of NTHi received
from laboratories in the United States, Canada, and Switzer-
land. Nine of these isolates lacked the infA-ksgA island. Thus,
of the 72 isolates studied, we identified 21 isolates that lack the
island. Of these, 15 were invasive (P  0.04). The 19 additional
invasive isolates also included 7 with sequences related to
lic2BC and 3 with sequences related to losAB, consistent with
the earlier observation that losAB is relatively rare among
invasive isolates.
Identification of group of closely related isolates. The pres-
ence or absence of the infA-ksgA island and its content corre-
late with several of the genetic and biochemical features known
to be variably present among H. influenzae strains (Table 4).
Isolates lacking the infA-ksgA island were more likely than
other isolates to contain lav or the HP2 bacteriophage. Two-
thirds of the isolates lacking this island were urease negative
but positive for indole and ornithine decarboxylase, making
them members of the relatively rare biotype V (23). All biotype
V strains were hia positive (P  0.007). The similarities of the
biotype V isolates led us to look carefully for differences
among them (Table 5). Although these isolates have several
features in common, they are heterogeneous with regard to the
presence of lysine decarboxylase activity, production of nitrite
from nitrate, arabinose fermentation, and the presence of the
lav and HP2 genes. It thus seems unlikely that they represent
a recently derived clone. We used MLST to determine the STs
for 11 strains that are biotype V, hmw negative, and negative
for the infA-ksgA island and for 13 strains of biotypes I, II, and
III. Eight of the biotype V strains formed a more distinct
cluster than any of the other strains, while one belonged to a
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Throat 17 (32.1) 12 5
Otitis 19 (35.8) 10 9
Invasive 17 (32.1) 11 6
Biochemical reactions
Indole 42 (79.2) 14 15 13 30 12 0.012
Urease 44 (83.0) 16 16 12 24 20 0.008
Omithine decarboxylase 24 (45.3) 8 5 11 23 1 0.0001
Lysine decarboxylase 16 (30.2) 7 3 6 16 0 0.0001
Arginine dihydrolase 3 (5.6) 3 0 0 2 1
Arabinose fermentation 9 (17.0) 7 1 1 0.003 8 1
Growth on citrate 5 (9.4) 3 0 2 4 1
Autotransporter lav 16 (30.2) 1 11 4 0.010 8 8
Bacteriophage HP2 4 (7.5) 0 1 3 4 0
Adhesin hia 29 (54.7) 9 8 12 28 1 0.0001
Genetic island flanked by purE and pepN
7-kb hif (pilus) only 2 (9.4) 0 2 0 1 1
hicAB only 27 (50.9) 7 10 10 9 18 0.0001
hicAB and hif 9 (17.0) 4 3 2 9 0 0.019
No island 15 (28.3) 6 4 5 14 1 0.004
Genetic island flanked by infA and ksgA
lic2BC or lic2C 31 (58.5) 10 11 10 17 14
losAB 10 (18.9) 5 4 1 6 4
No island 12 (22.6) 2 4 6 10 2
a As described in the text, strains were scored for the presence of hmw and other genes based on the results of PCR amplification. The nature of the sequence
amplified was confirmed by sequencing for a subset of strains. Strains that scored positive for a genetic locus may not contain the complete locus and may not express
the gene product(s). hmw, absence of hmw; hmw, presence of hmw.
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neighboring lineage; the remaining two biotype V strains were
closely related to each other but not to other strains (Fig. 2).
Replacement of the urease locus by an mtrF homolog. The
strong correlation between urease activity and the presence of
an infA-ksgA island (P  0.0005) may be due to genetic link-
age, since these two loci are separated by only 4 kb. A search
of the available H. influenzae genome sequences revealed that
strains Rd KW20, R2846, and 86-028NP each contain a cluster
of seven genes (designated HI0535 to HI0541 in Rd KW20)
with homology to the well-characterized urease genes of Kleb-
siella aerogenes (30). In each case this locus is flanked by ho-
mologs of aspA and groES. In strain R2866, which is urease
negative, the seven-gene cluster is replaced by a single gene
with homology to the gonococcal gene mtrF (Fig. 1). Using
PCR primers that hybridized to the aspA and groES genes, we
were able to amplify the expected 9-kb product from genomic
DNA of each of four urease-positive strains. Partial sequenc-
ing of the PCR products showed that each was similar to the
urease locus of strain Rd KW20. The same PCR primers
yielded a 4-kb product from each of nine urease-negative
strains, consistent with the sequence of R2866. Partial se-
quencing of these 4-kb products showed that all were very
similar to that of R2866.
RFLP analysis of the hif locus. In previous work (T.
Mhlanga-Mutangadura and M. Golomb, unpublished) on the
heterogeneity of the hif locus, we had identified three NTHi
isolates, R3101, R3151, and R3157, that had hifA sequences
nearly identical to that of R2866 and in which the 7-kb hif locus
had a PstI RFLP pattern similar to that of R2866. We now
extended that work to the strains found in this study to have a
7-kb hif locus. Consistent with previous work, several patterns
were identified. R3265, a throat isolate, had the same RFLP
pattern as R2866. All of the isolates with this pattern belonged
to biotype V and lacked the infA-ksgA island.
Serum resistance. Our prototype invasive nontypeable
strain, R2866 (Int1), had previously been shown to survive in
40% normal human serum much longer than the laboratory
strain Rd KW20 or the nontypeable strain U11 (49). We hy-
pothesized that the in vitro serum resistance of R2866 reflected
a virulence trait that might be shared with other invasive NTHi
isolates. In the present study we used a more quantitative assay
to evaluate the serum resistance of the 53 clinical isolates
described above. We found that the range of IC50s for clinical
NTHi isolates was nearly as wide as the difference between
FIG. 1. Gene arrangement at two variable loci. (A) Variable content of the genetic island between infA and ksgA. Of the 99 NTHi isolates
studied, 31 lack this island, as depicted for Rd KW20 and R2866. Forty-five isolates contain lic2B and lic2C, as shown for RM7004 (16, 20).
Seventeen contain losA and losB, as shown for R2846. Six isolates contain lic2C without lic2B (not shown). (B) The urease locus of Rd KW20 and
R2846 is replaced in R2866 by mtrF. We amplified the region between aspA and groES of 12 urease-negative isolates, and all yielded a 4-kb product
consistent with mtrF. Homology with mtrF was confirmed by sequencing for seven of the isolates.
TABLE 4. Association of the infA-ksgA island with other
variable regions
Region or feature









Integrative plasmid 3 2 3 1
Bacteriophage HP2 3 0 1 0
lav-related sequencea 7 2 6 1
Genetic island flanked by purE
and pepN
7-kb hif (pilus) only 0 0 1 1
hicAB only 5 3 17 2
hicAB and hif 4 3 2 0
No island 3 4 7 1
hia and hmw-related
sequences
hia only 9 4 14 1
hmw only 2 4 10 3
Both hia and hmw 0 0 1 0
Neither 1 2 2 0
Urease negative, mtrF positive 8 0 1 0
a Isolates lacking an infA-ksgA island are more likely to contain lav-related
sequences than other isolates (P  0.02).
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encapsulated and unencapsulated strains and that R2866 was
one of the most resistant strains in our collection. However,
the 16 additional invasive isolates that we tested were not
overall more serum resistant than otitis isolates and were only
slightly more serum resistant than throat isolates. The IC50
range for the invasive isolates was broad, from 1.9% to 13.3%,
and this range was similar to that for the other two groups. It
is clear that in vitro serum resistance is neither common to
all invasive isolates nor a specific characteristic of this group
(Fig. 3).
DISCUSSION
While it is well known that NTHi isolates are more hetero-
geneous than type b isolates, the extent to which the hetero-
geneous characteristics are correlated with each other or with
the anatomic site of isolation is not well understood. We had
previously identified genes encoding the autotransporter Lav
and bacteriophage HP2 in the invasive isolate R2866 and hy-
pothesized that they might be involved in the unusual virulence
of this strain (9, 48). In this study we found that the lav gene is
indeed rare in throat isolates but is present in many otitis
isolates and in only about one-fourth of invasive isolates. Only
4 of the 53 isolates studied in this work contained HP2; 3 of
these are invasive. R2866 also contains a 53-kb region that
appears to be an integrated plasmid similar to those described
for other Haemophilus strains (28). We identified sequences
characteristic of the plasmid in 11 isolates, only 1 of which was
a throat isolate. None of the genetic loci or biochemical reac-
tions we studied were found to be consistently present in in-
vasive isolates. A genetic island flanked by infA and ksgA was
identified in most throat and otitis isolates but was absent in
40% of invasive isolates. When present, this island contains
lipopolysaccharide biosynthetic genes, as discussed below.
The ease with which H. influenzae strains exchange DNA
and the observed genetic heterogeneity among NTHi isolates
might have suggested that variable genes would occur ran-
domly. A high rate of recombination in otitis media isolates has
been reported (7). However, we found that certain genetic loci
occurred together much more often than would occur by
chance. Many of the characteristics we examined were signif-
icantly associated with the presence of sequences related to
hmw or hia genes. Because we detected these genes by PCR
amplification of an internal portion of each gene, we cannot be
sure that the strains we scored positive for an adhesin actually
contain the complete genetic locus required to express HMW
or Hia adhesins. Indeed, some strains appeared to contained
only a fragment of the hia gene. It is also possible that some of
the strains we scored negative contained gene variants that
differed slightly at one of the primer binding sites. St. Geme et
al. reported that nearly all H. influenzae strains contain genes
encoding either the Hia adhesin or the HMW adhesins (39).
hia is an allele of the hsf gene found in encapsulated strains.
This led to the hypothesis that hia-containing strains may have
evolved from an encapsulated ancestor. In support of this idea,
the insertion element IS1016, which is found in the cap locus of
encapsulated strains, was found to hybridize to genomic DNA
of 6 hia-containing NTHi isolates out of 9 isolates tested but
not to hybridize to any of the 47 hmw-containing isolates that
were tested (39). Our observation that several genetic and
biochemical traits are correlated with the presence of a se-
quence related to hmw or hia is consistent with the idea that
these genes are found in two distinct lineages. Indole, ornithine
decarboxylase, and lysine decarboxylase were all significantly
TABLE 5. Characteristics of biotype V isolates
Characteristic






C1344 C470 R3157 R2866 R3174 R3176 R3567 R3569 R3631 R3570
Geographic region SP NL WA MA OH WA SW SW GA GA AR GA
ST 239 240 234 187 238 99 241 242 236 237 236 ND
Serum IC50 2.75 2.72 10.47 12.93 2.01 11.52 ND ND 3.41 7.88 2.01 3.40
Biochemical reactions
Lysine decarboxylase            
Nitrate reduction            
Arabinose fermentation            
Growth on citrate            
PCR data
Plasmid       ND ND    
Autotransporter lav       ND ND    
Bacteriophage HP2       ND ND    
Adhesin hmw            
Adhesin hia 3.8 kb 3.5 kb 3.5 kb 3.5 kb 4 kb 4 kb 6 kb 6 kb 3.5 kb 3.5 kb 5 kb 3.5 kb
purE-pepN island hic-hif hic-hif hic hic-hif hic-hif hic-hif ND ND  hic  hic
infA-ksgA island            lic2BC
aspA-groES island mtrF mtrF mtrF mtrF mtrF mtrF mtrF mtrF mtrF mtrF mtrF mtrF
a The table summarizes data for 12 biotype V isolates (indole positive, ornithine decarboxylase positive, urease negative). Nine of these were identified in the study
for which results are given in Table 3, and three (R3101, R3567, R3569) were identified from separate studies. All of the biotype V isolates were also hmw negative
and hia positive, and all except one (R3570) lacked a genetic island between infA and ksgA. Of the 53 isolates described in Table 3, the 9 biotype V isolates were more
likely than the 44 non-biotype V isolates to contain a sequence related to the gene for the autotransporter Lav (P  0.061) or bacteriophage HP2 (P  0.0005). They
were also more likely to have been isolated from blood, but the difference is not statistically significant (P  0.109). Such clustering of traits is so unusual in H. influenzae
as to raise the question of whether these isolates are clonal. These strains are from different parts of the world (SP, Spain; NL, The Netherlands; WA, Washington state;
MA, Massachusetts; SW, Switzerland; OH, Ohio; GA, Georgia) and differ in sugar fermentation and other biochemical reactions. Phylogenetic analysis of 11 of these
strains showed that they are related (Fig. 2). ND, not determined.
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more prevalent among hia-containing isolates than among
hmw-containing isolates. The hmw-containing isolates in our
study were uniformly urease positive, while nearly one-third of
the hia-containing isolates were urease negative.
Within the hmw-negative, hia-positive isolates, we identified
a group of 11 biotype V isolates that shared several character-
istics of the invasive strain R2866 (Table 5). All the biotype V
strains except one lacked the genetic island between ksgA and
infA. Some of the isolates lacking an infA-ksgA island con-
tained a hif locus with a characteristic RFLP pattern. Isolates
lacking an infA-ksgA island were also more likely than other
isolates to contain lav genes. Bacteriophage HP2 was found
only in biotype V strains.
With the exception of the hmw-hia dichotomy (39), associ-
ations among variable genetic loci of H. influenzae have not
been previously noted. Because natural transformation and
other means of genetic exchange readily disrupt linkages, gene
associations must be explained by a recent shared lineage or by
shared adaptive strategies or requirements for virulence. The
urease locus and the infA-ksgA locus are linked within 4 kb and
might have persisted in linkage disequilibrium. However, the
associations with the hia gene and the hif RFLP pattern cannot
be explained in this way. It is possible that the isolates lacking
an infA-ksgA island are closely related to each other, although
they were derived from different parts of the United States as
well as from Canada and Europe. As noted above, the isolates
in this group were more likely to have been cultured from
blood than from ear aspirates or nasopharyngeal samples. This
suggests that they may share virulence determinants. Phyloge-
netic analysis by MLST showed that 9 of 11 biotype V isolates
formed a single cluster, while 2 other biotype V isolates were
closely related to each other but not to the cluster of 9. Typing
of 13 strains of other biotypes showed some tendency for
strains to cluster by biotype and the by presence of an hmw-
related sequence. Further evaluation of the correlation be-
tween MLST and other characteristics of NTHi is ongoing.
We found that in the urease-negative isolates we studied, the
urease locus was invariably replaced by a gene with homology
to the mtrF gene found in N. gonorrhoeae and N. meningitidis.
In gonococci, mtrF encodes a predicted membrane protein that
has been reported to be involved in resistance to detergents
and hydrophobic antibiotics, in conjunction with the resis-
FIG. 2. UPGMA (unweighted pair-group method with arithmetic averages) dendrogram based on the pairwise differences in the MLST allelic
profiles of 24 NTHi isolates. Eleven strains that share the properties of belonging to biotype V, lacking hmw-related sequence, and lacking a genetic
island flanked by infA and ksgA are clustered on the dendrogram. Of these, eight are most closely related: R3569, C1344, R2866, C470, R3157,
R3176, R3567, and R3631. R3174 is less closely related, and R3265 and R3101 are closely related to each other but not to the other biotype V
isolates. The remaining isolates for which MLST was determined belong to biotype I, II, or III. Those containing hmw-related sequence are
separated on the dendrogram from the strains lacking hmw.
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tance-nodulation-cell division (RND) pump MtrCDE (45),
which does not appear to be present in any of the H. influenzae
strains that have been sequenced. A less closely related ho-
molog, abgT, is thought to encode a transporter that allows an
Escherichia coli mutant that is defective in p-aminobenzoate
synthesis to utilize p-aminobenzoyl-glutamate (21). It thus
seems likely that the H. influenzae MtrF homolog is involved in
transport, but the substrate cannot be determined without ex-
perimental data.
We found that when the infA-ksgA region contains an insert,
the locus may consist of lic2BC, as previously seen for type b
isolates (15), of lic2C only, or of two genes with homology to
losA and losB of H. ducreyi. The prevalence of lic2B and lic2C
has been studied previously, though not in invasive isolates.
Hood et al. reported that 13 of 27 NTHi strains studied con-
tained lic2C (20). Pettigrew et al. examined 90 throat and 48
otitis isolates and found lic2B in one-half of the otitis isolates
but only 14% of the throat isolates (35). In contrast, we found
for throat, otitis, and invasive isolates that about half in each
group contained lic2BC. However, it is possible that our small
sample of throat isolates (17 isolates) had an atypical distribu-
tion of genes at this locus. The losAB genes have not been
studied previously in H. influenzae. We found that the infA-
ksgA island contained losAB in about one-third of our throat
and otitis isolates but in very few invasive isolates.
Without further study, it is not possible to determine
whether the variation we see in the structure of the infA-ksgA
region has a direct role in H. influenzae biology. Certainly the
lic2BC and losAB genes are likely to affect the structure of
lipopolysaccharide and thereby the interaction of bacteria with
the host. It is also possible that these genes are markers for
other characteristics that collectively affect the ability of a
given strain to colonize or cause disease. We noted that the
genome sequences of both R2846 and R2866 contain ho-
mologs of losAB at sites distant from the infA-ksgA region. In
R2846, the second losA homolog contains a frameshift and
appears unlikely to encode an active product.
NTHi strains isolated from the blood of ill children were as
likely to be sensitive to serum as throat and otitis isolates. One
explanation for this unexpected finding is that our laboratory
stocks differ genetically from the bacterial population in the
patients during infection. H. influenzae is subject to high-fre-
quency, reversible gain or loss of phenotypes such as hemag-
glutination (reflecting piliation), colony morphology, or reac-
tivity of lipopolysaccharide with monoclonal antibodies (11, 24,
46). The molecular basis of this phase variation is variation in
the length of tandem repeat regions, often within the coding
region of genes (47). A growing culture of any H. influenzae
strain thus contains a large number of variants that differ from
each other in the expression of one or more genes. A change
in environmental conditions may result in selection of a differ-
ent population of variants, and a culture that has been derived
from a single colony (as is likely to happen during isolation in
a clinical laboratory) and then propagated in the lab may
contain a mixture of variants very different from that in the
patient’s blood. Although R2866, the first invasive NTHi strain
studied, has retained serum resistance in the lab, this may be
the result of a fortuitous subculture of a resistant colony. The
range of serum resistance observed for other clinical isolates
may reflect true differences among these isolates but may also
indicate that for some isolates we are working with serum-
sensitive variants and for other isolates our laboratory stocks
happen to consist largely of serum-resistant variants.
Overall, our data indicate that NTHi isolates from invasive
disease are not homogeneous: they differ in genotype and in
resistance to human serum. It is possible that invasiveness can
result from more than one combination of biologic capabilities
and that different invasive strains have different sets of genes
mediating these functions. It is also possible that all invasive
isolates share a gene or group of genes that has not yet been
discovered. Several of the biochemical and genetic traits we
studied were correlated with each other and particularly with
the hia and hmw genes, supporting the idea that NTHi strains
may cluster into distinct lineages, although the lines may be
blurred by genetic exchange. We have recently determined the
complete genome sequence of the invasive strain R2866 and an
otitis strain, R2846 (strain 12). Each of these strains contains
30 to 40 genetic loci not present in the previously sequenced
strain, Rd KW20. Analysis of these novel loci will add to our
understanding of the genetic relationships among NTHi iso-
lates and may identify genetic determinants characteristic of
strains associated with invasive disease and with otitis media.
This will aid in the understanding of the virulence mechanisms
required for nasopharyngeal bacteria to cause mucosal or sys-
temic disease.
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ADDENDUM IN PROOF
Since acceptance of this paper, we discovered that the bexA
primers listed in Table 2 are able to amplify bexA from sero-
type b, c and d strains but do not reliably amplify bexA from
serotype a or e strains. On testing the strains listed in Table 1
for bexA using the primers described by Falla et al. (J. Clin
Microbiol. 32: 2382–2386, 1994), strains R3049, R3172, R3173,
R3368, and R3595 were found to be positive. Strain R3368 was
biotype I and negative for lysine decarboxylase, arginine dihy-
drolase, citrate, and arabinose. It was positive for hia and
losAB sequences and negative for hmw, lav, HP2, plasmid, hif,
and hic sequences. Strains R3049 and R3173 contain the
lic2BC genes, and R3172 and R3595 contain losAB. Elimina-
tion of R3368-derived data from Table 3 increased each of the
reported P values slightly, with each P value remaining 0.02.
Eliminating data on the remaining strains from the section
entitled “Lipopolysaccharide biosynthetic island flanked by
infA and ksgA” did not alter the conclusions.
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